CN104140412B - For preparing the intermediate of Bruguiesulfurol, its synthetic method, intermediate and purposes - Google Patents
For preparing the intermediate of Bruguiesulfurol, its synthetic method, intermediate and purposes Download PDFInfo
- Publication number
- CN104140412B CN104140412B CN201310165150.3A CN201310165150A CN104140412B CN 104140412 B CN104140412 B CN 104140412B CN 201310165150 A CN201310165150 A CN 201310165150A CN 104140412 B CN104140412 B CN 104140412B
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- reaction
- acid
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 *OC1C=SSC1 Chemical compound *OC1C=SSC1 0.000 description 1
- AUONKDYIRKQAFU-UHFFFAOYSA-N C/C=S(\C1)/SCC1O Chemical compound C/C=S(\C1)/SCC1O AUONKDYIRKQAFU-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
技术领域technical field
本发明涉及化学合成领域,更具体而言,本发明涉及制备具有抗II型糖尿病活性的天然产物新木榄二硫醇(bruguiesulfurol)的新型中间体、其合成方法及其中间体,以及制备新木榄二硫醇的方法。The present invention relates to the field of chemical synthesis, more specifically, the present invention relates to the preparation of novel intermediates of natural product bruguiesulfurol (bruguiesulfurol) with anti-type II diabetes activity, its synthetic method and its intermediates, and the preparation of new The method of ladenithiol.
背景技术Background technique
新木榄二硫醇是从红树林植物木榄中分离得到的一种具有全新骨架结构的五元环二硫化合物(Phytochemistry2009,70,2096-2100),其结构式如下所示:New clover dithiol is a five-membered ring disulfide compound with a new skeleton structure isolated from the mangrove plant clover (Phytochemistry2009, 70, 2096-2100), and its structural formula is as follows:
(式I)。 (Formula I).
研究显示,此化合物对于II型糖尿病靶标蛋白酪氨酸磷酸酯酶1B(proteintyrosine phosphatase1B,PTP1B)具有良好的抑制活性(其抑制浓度为IC50=17.5μΜ),在治疗II型糖尿病及其并发症方面具有很好的应用价值。然而,通过分离手段能够得到的量有限,由此限制了对该化合物进行深入的活性研究以及成药性的评价。Studies have shown that this compound has good inhibitory activity on type II diabetes target protein tyrosine phosphatase 1B (proteintyrosine phosphatase1B, PTP1B) (its inhibitory concentration is IC 50 =17.5μM), and it is effective in the treatment of type II diabetes and its complications It has good application value. However, the amount that can be obtained by means of separation is limited, thus limiting the in-depth activity research and druggability evaluation of the compound.
发明内容Contents of the invention
针对现有技术中存在的上述和其他问题,本发明人进行了广泛深入的研究,并最终完成本发明。In view of the above and other problems existing in the prior art, the present inventor has conducted extensive and in-depth research, and finally completed the present invention.
因此,本发明的一个目的是提供一种如下式II所示的化合物,该化合物可以用于制备新木榄二硫醇。Therefore, an object of the present invention is to provide a compound shown in the following formula II, which can be used for the preparation of neoclamedithiol.
式II其中,R为保护基。Formula II wherein, R is a protecting group.
本发明的另一个目的是提供一种上式II所示的化合物的制备方法。Another object of the present invention is to provide a preparation method of the compound represented by the above formula II.
本发明的还一个目的是提供一种新木榄二硫醇的合成方法。Still another object of the present invention is to provide a kind of synthetic method of new oledithiol.
本发明的再一个目的是提供一种如下式III所示的化合物,该化合物可以用于制备上式II所示的化合物。Another object of the present invention is to provide a compound represented by the following formula III, which can be used to prepare the compound represented by the above formula II.
式III其中,R为保护基,以及X为氯、溴或碘。Formula III wherein R is a protecting group and X is chlorine, bromine or iodine.
根据本发明的第一个方面,提供了一种如下式II所示的化合物:According to a first aspect of the present invention, a kind of compound shown in following formula II is provided:
式II其中,R为保护基。Formula II wherein, R is a protecting group.
本发明中,优选地,所述保护基可为对溴苯甲酰基、对氯苯甲酰基、对碘苯甲酰基、四氢吡喃基,更优选为对溴苯甲酰基、四氢吡喃基,最优选为四氢吡喃基。In the present invention, preferably, the protecting group can be p-bromobenzoyl, p-chlorobenzoyl, p-iodobenzoyl, tetrahydropyranyl, more preferably p-bromobenzoyl, tetrahydropyranyl group, most preferably tetrahydropyranyl.
根据本发明的第二个方面,提供了一种上式II所示的化合物的制备方法,该方法包括:According to a second aspect of the present invention, there is provided a method for preparing a compound represented by the above formula II, the method comprising:
c)使式III化合物与二硫化钠在相转移催化剂作用下反应得到式II化合物,其中,R为保护基,以及X为氯、溴或碘。c) reacting the compound of formula III with sodium disulfide under the action of a phase transfer catalyst to obtain the compound of formula II, wherein R is a protecting group, and X is chlorine, bromine or iodine.
本发明中,在步骤c)中,优选地,所述式III化合物与二硫化钠的摩尔比为1:1~5,更优选1:1~2;优选地,所述相转移催化剂为苄基三乙基氯化铵、四丁基溴化铵、四丁基氯化铵、四丁基硫酸氢铵、三辛基甲基氯化铵、十二烷基三甲基氯化铵或十四烷基三甲基氯化铵;优选地,反应所用溶剂为二氯甲烷或氯仿与水的混合溶剂;优选地,反应温度为0℃~50℃,更优选0℃~20℃;和/或,优选地,反应时间为1~40小时,更优选2~15小时。In the present invention, in step c), preferably, the molar ratio of the compound of formula III to sodium disulfide is 1:1-5, more preferably 1:1-2; preferably, the phase transfer catalyst is benzyl Triethylammonium chloride, tetrabutylammonium bromide, tetrabutylammonium chloride, tetrabutylammonium bisulfate, trioctylmethylammonium chloride, dodecyltrimethylammonium chloride or Tetraalkyltrimethylammonium chloride; Preferably, the solvent used for the reaction is a mixed solvent of dichloromethane or chloroform and water; Preferably, the reaction temperature is 0°C to 50°C, more preferably 0°C to 20°C; and/ Or, preferably, the reaction time is 1-40 hours, more preferably 2-15 hours.
在上式II所示的化合物的制备方法中,优选地,所述式III化合物可以由以下步骤制备:In the preparation method of the compound shown in the above formula II, preferably, the compound of the formula III can be prepared by the following steps:
a)使式V化合物经开环反应得到式IV化合物,其中,X的定义如上所述;a) making the compound of formula V undergo a ring-opening reaction to obtain a compound of formula IV, wherein X is as defined above;
b)将式IV化合物的羟基进行保护得到式III化合物,其中,R的定义如上所述。b) Protecting the hydroxyl group of the compound of formula IV to obtain the compound of formula III, wherein R is as defined above.
本发明中,在步骤a)中,对所述开环反应的反应条件没有特别限制,只要能够进行开环反应即可。作为一个实例,所述开环反应可以在例如盐酸、氢溴酸或氢碘酸的存在下进行。优选地,式V化合物与盐酸、氢溴酸或氢碘酸的摩尔比为1:1~5,更优选1:1~3;优选地,反应所用溶剂可以为四氢呋喃、乙醚、二氧六环、苯、甲苯、水或其混合物;优选地,反应温度可以为-40℃~室温,更优选-20℃~0℃,最优选-10℃~0℃;和/或,优选地,反应时间可以为1~10小时,更优选1~5小时。In the present invention, in step a), the reaction conditions for the ring-opening reaction are not particularly limited, as long as the ring-opening reaction can be performed. As an example, the ring-opening reaction can be performed in the presence of, for example, hydrochloric acid, hydrobromic acid or hydroiodic acid. Preferably, the molar ratio of the compound of formula V to hydrochloric acid, hydrobromic acid or hydroiodic acid is 1:1 to 5, more preferably 1:1 to 3; preferably, the solvent used for the reaction can be tetrahydrofuran, ether, dioxane , benzene, toluene, water or a mixture thereof; preferably, the reaction temperature may be -40°C to room temperature, more preferably -20°C to 0°C, most preferably -10°C to 0°C; and/or, preferably, the reaction time It may be 1 to 10 hours, more preferably 1 to 5 hours.
本发明中,在步骤b)中,对所述羟基保护反应的类型没有特殊限制,只要能够保护羟基即可。所述羟基保护反应可以采用本领域中的任何羟基保护反应来进行。作为一个实例,可以使所述式IV化合物与3,4-二氢吡喃在催化剂的作用下得到羟基被四氢吡喃基(THP)保护的式III化合物,其中,优选地,所述式IV化合物与3,4-二氢吡喃的摩尔比为1:1~10,更优选1:1~3。所述催化剂可以为选自对甲苯磺酸、吡啶对甲苯磺酸盐、三氟甲磺酸、乙酸和樟脑磺酸中的一种或多种;反应所用溶剂可以为甲醇、乙醇、异丙醇、乙醚、四氢呋喃、二氧六环、苯、甲苯、氯仿、二氯甲烷、二甲亚砜或其混合物;优选地,反应时间可以为2~10小时;和/或,优选地,反应温度可以为-78℃~室温。In the present invention, in step b), there is no special limitation on the type of the hydroxyl protection reaction, as long as the hydroxyl group can be protected. The hydroxyl protection reaction can be carried out by using any hydroxyl protection reaction in the art. As an example, the compound of formula IV can be combined with 3,4-dihydropyran under the action of a catalyst to obtain a compound of formula III whose hydroxyl group is protected by tetrahydropyranyl (THP), wherein, preferably, the compound of formula The molar ratio of compound IV to 3,4-dihydropyran is 1:1-10, more preferably 1:1-3. Described catalyzer can be selected from one or more in p-toluenesulfonic acid, pyridine p-toluenesulfonic acid salt, trifluoromethanesulfonic acid, acetic acid and camphorsulfonic acid; Reaction used solvent can be methanol, ethanol, Virahol , ether, tetrahydrofuran, dioxane, benzene, toluene, chloroform, methylene chloride, dimethyl sulfoxide or a mixture thereof; preferably, the reaction time can be 2 to 10 hours; and/or, preferably, the reaction temperature can be -78°C to room temperature.
根据本发明的第三个方面,提供了新木榄二硫醇的合成方法,该方法包括:According to a third aspect of the present invention, there is provided a synthetic method of neoclamedithiol, the method comprising:
d)使式II化合物经过氧化并脱保护得到式I化合物,其中,R为保护基。d) oxidizing and deprotecting the compound of formula II to obtain the compound of formula I, wherein R is a protecting group.
本发明中,在步骤d)中,对氧化反应所用的氧化剂没有特殊限制,只要能够实现本发明的氧化目的即可,例如,所述氧化剂可以为间氯过氧苯甲酸或过氧叔丁醇。优选地,反应所用溶剂可以为二氯甲烷、四氢呋喃、1,4-二氧六环或氯仿;优选地,反应温度可以为0℃~60℃,更优选0℃~20℃;和/或,反应时间可以为1~40小时,更优选2~15小时。In the present invention, in step d), there is no special limitation to the oxidizing agent used in the oxidation reaction, as long as the oxidation purpose of the present invention can be realized, for example, the oxidizing agent can be m-chloroperoxybenzoic acid or peroxy tert-butanol . Preferably, the solvent used for the reaction may be dichloromethane, tetrahydrofuran, 1,4-dioxane or chloroform; preferably, the reaction temperature may be 0°C to 60°C, more preferably 0°C to 20°C; and/or, The reaction time may be 1 to 40 hours, more preferably 2 to 15 hours.
本发明的一个优选实施方式中,在步骤d)中,用式4化合物在氧化剂作用下进行氧化并脱保护得到化合物式I,反应式如下:In a preferred embodiment of the present invention, in step d), the compound of formula 4 is oxidized and deprotected under the action of an oxidizing agent to obtain compound formula I, and the reaction formula is as follows:
式4 式I。 Formula 4 Formula I.
本发明中,例如,其中,作为式II化合物的具体实例的所述式4化合物可以按下述方法制备:In the present invention, for example, wherein, the compound of formula 4 as a specific example of the compound of formula II can be prepared as follows:
在步骤a)中,以环氧溴丙烷(式1化合物)为起始原料,在氢溴酸的作用下,打开环氧得到1,3-二溴-2-丙醇(式2化合物);In step a), using epibromohydrin (compound of formula 1) as the starting material, under the action of hydrobromic acid, the epoxy is opened to obtain 1,3-dibromo-2-propanol (compound of formula 2);
在步骤b)中,1,3-二溴-2-丙醇(式2化合物)与3,4-二氢吡喃在吡啶对甲苯磺酸盐的催化作用下得到羟基被保护的式3化合物,In step b), 1,3-dibromo-2-propanol (compound of formula 2) and 3,4-dihydropyran are catalyzed by pyridine p-toluenesulfonate to obtain compound of formula 3 with protected hydroxyl group ,
在步骤c)中,式3化合物与二硫化钠水溶液在相转移催化剂四丁基溴化胺的作用下反应生成式4化合物;其中,二硫化钠水溶液可以通过使含有结晶水的硫化钠与硫粉在加热的条件下反应制备。In step c), the compound of formula 3 reacts with the aqueous solution of sodium disulfide under the action of the phase transfer catalyst tetrabutylammonium bromide to generate the compound of formula 4; wherein the aqueous solution of sodium disulfide can be obtained by making sodium sulfide containing crystal water and sulfur The powder is prepared by reaction under heating conditions.
上述具体合成方法可以用下面反应路线I表示:Above-mentioned specific synthetic method can represent with following reaction scheme I:
式1 式2 式3 式4 Formula 1 Formula 2 Formula 3 Formula 4
反应路线IReaction Scheme I
因此,本发明提供的天然产物新木榄二硫醇的合成方法,合成路线新颖,操作简便,收率高,重现性好,适合工业化生产,解决目前该类化合物仅能够由红树林植物浸膏中效率极低的提取分离制备的问题。Therefore, the synthetic method of the natural product neocladildithiol provided by the present invention has novel synthetic route, simple and convenient operation, high yield, good reproducibility, and is suitable for industrialized production. The problem of extremely inefficient extraction and separation preparation in creams.
具体实施方式detailed description
在下文中,将通过示例性提出的实施例来更加详细地描述本发明,然而,本发明的范围并不限于实施例。Hereinafter, the present invention will be described in more detail through exemplarily proposed embodiments, however, the scope of the present invention is not limited to the embodiments.
实施例Example
NMR用Bruker-AMX300核磁共振仪测定;EI-MS用Finnigan-MAT-95质谱仪测定;柱层析硅胶柱、薄层硅胶板均为青岛海洋化工有限公司或烟台化工研究所实验厂柱硅胶H(100-200目,200-300目,10-40μM)。NMR was measured by Bruker-AMX300 nuclear magnetic resonance instrument; EI-MS was measured by Finnigan-MAT-95 mass spectrometer; column chromatography silica gel column and thin-layer silica gel plate were column silica gel H of Qingdao Ocean Chemical Co., Ltd. or Yantai Chemical Research Institute Experimental Factory (100-200 mesh, 200-300 mesh, 10-40μM).
环氧溴丙烷、硫粉、硫化钠,化学纯,中国医药集团化学试剂有限公司。Epibromohydrin, sulfur powder, sodium sulfide, chemically pure, China Pharmaceutical Group Chemical Reagent Co., Ltd.
实施例1:1,3-二溴-2-丙醇(式IV化合物)的合成Embodiment 1: Synthesis of 1,3-dibromo-2-propanol (compound of formula IV)
在插有温度计的三口瓶中加入20克环氧溴丙烷(式V化合物),降温至0℃以下,缓慢滴加32克氢溴酸(40%),过程中剧烈放热,控制温度低于5℃,加料完毕,保持0℃搅拌4小时,乙醚萃取两次,合并有机相,饱和碳酸氢钠水溶液洗涤有机相,再用水洗涤有机相,有机相用无水硫酸镁干燥,过滤减压蒸去溶剂,得到无色油状物(式IV化合物)27克,收率:85%。Add 20 grams of epibromopropane (compound of formula V) into a three-necked bottle with a thermometer, cool down to below 0°C, slowly add 32 grams of hydrobromic acid (40%) dropwise, during the process of violent heat release, control the temperature below 5°C, after the addition was complete, keep stirring at 0°C for 4 hours, extract twice with ether, combine the organic phases, wash the organic phase with saturated aqueous sodium bicarbonate solution, and then wash the organic phase with water, dry the organic phase with anhydrous magnesium sulfate, filter and evaporate under reduced pressure The solvent was removed to obtain 27 g of a colorless oil (compound of formula IV), yield: 85%.
1H NMR(400MHz,CDCl3):δ4.00(m,1H),3.58(d,1H),3.56(d,1H),2.6(br,1H)。 1 H NMR (400 MHz, CDCl 3 ): δ 4.00 (m, 1H), 3.58 (d, 1H), 3.56 (d, 1H), 2.6 (br, 1H).
实施例2:2-(1,3-二溴-2-丙氧基)-四氢吡喃(式III化合物)的合成Example 2: Synthesis of 2-(1,3-dibromo-2-propoxy)-tetrahydropyran (compound of formula III)
1.09克1,3-二溴-2-丙醇(式IV化合物)溶解于10毫升四氢呋喃中,再加入0.84克3,4-二氢吡喃,接着加入125毫克吡啶对甲基苯磺酸盐,室温搅拌2小时,加入30毫升乙酸乙酯稀释,用30毫升水洗两次,再用30毫升饱和食盐水洗涤,有机相用无水硫酸钠干燥,过滤浓缩,残余物以石油醚:乙酸乙酯(体积比100:1)为洗脱液,经硅胶柱层析得到无色油状物(式III化合物)1.20克,收率80%。1.09 g of 1,3-dibromo-2-propanol (compound of formula IV) was dissolved in 10 ml of tetrahydrofuran, then 0.84 g of 3,4-dihydropyran was added, followed by 125 mg of pyridine p-toluenesulfonate , stirred at room temperature for 2 hours, added 30 milliliters of ethyl acetate for dilution, washed twice with 30 milliliters of water, and then washed with 30 milliliters of saturated brine, the organic phase was dried over anhydrous sodium sulfate, concentrated by filtration, and the residue was washed with petroleum ether: ethyl acetate The ester (volume ratio 100:1) was used as the eluent, and 1.20 g of a colorless oil (compound of formula III) was obtained by silica gel column chromatography, with a yield of 80%.
1H NMR(400MHz,CDCl3):δ4.76-4.79(m,1H),3.88-4.04(m,2H),3.51-3.71(m,5H),1.53-1.87(m,6H)。 1 H NMR (400 MHz, CDCl 3 ): δ 4.76-4.79 (m, 1H), 3.88-4.04 (m, 2H), 3.51-3.71 (m, 5H), 1.53-1.87 (m, 6H).
实施例3:式II化合物的合成Embodiment 3: the synthesis of formula II compound
2.85克九水硫化钠溶解在10毫升水中,加入380毫克硫粉,加热至50℃,待硫粉完全溶解在溶液中,得到淡黄色溶液,冷却至室温,将该溶液加入到溶解有1.20克式III化合物的30毫升的氯仿溶液中,加入少量相转移催化剂四丁基溴化铵,溶液变成黑色,常温搅拌12小时,加入20毫升水,分层,氯仿萃取水层,合并有机相,用无水硫酸镁干燥,过滤,浓缩,残余物以石油醚:乙酸乙酯(体积比200:1)为洗脱液,经硅胶柱层析得到无色油状物(式II化合物)500毫克,收率61%。Dissolve 2.85 grams of sodium sulfide nonahydrate in 10 milliliters of water, add 380 milligrams of sulfur powder, heat to 50 ° C, and wait until the sulfur powder is completely dissolved in the solution to obtain a light yellow solution, cool to room temperature, add this solution to the dissolved 1.20 grams In the chloroform solution of 30 milliliters of the compound of formula III, add a small amount of phase transfer catalyst tetrabutylammonium bromide, the solution turns black, stir at room temperature for 12 hours, add 20 milliliters of water, separate layers, extract the aqueous layer with chloroform, combine organic phase, Dry over anhydrous magnesium sulfate, filter, concentrate, and the residue uses petroleum ether:ethyl acetate (volume ratio 200:1) as the eluent, and obtains 500 mg of a colorless oil (compound of formula II) through silica gel column chromatography, Yield 61%.
1H NMR(400MHz,CDCl3):δ4.78-4.84(m,1H),4.69-4.72(m,1H),3.82-3.89(m,1H),3.49-3.56(m,1H),3.11-3.28(m,4H),1.54-1.86(m,6H)。 1 H NMR (400MHz, CDCl 3 ): δ4.78-4.84(m,1H),4.69-4.72(m,1H),3.82-3.89(m,1H),3.49-3.56(m,1H),3.11- 3.28(m,4H),1.54-1.86(m,6H).
EI-MS:206[M]+。EI-MS: 206[M] + .
实施例4:式I化合物的合成Embodiment 4: the synthesis of formula I compound
170毫克式II化合物溶解在10毫升的二氯甲烷中,降温至0℃,加入300毫克间氯过氧苯甲酸,保持0℃搅拌1小时,常温搅拌2小时,加入10毫升水,分层,二氯甲烷萃取水层,合并有机相,用无水硫酸镁干燥,过滤,浓缩,残余物以石油醚:乙酸乙酯(体积比2:1)为洗脱液,经硅胶柱层析得到白色固体(式I化合物)30毫克,收率24%。170 mg of the compound of formula II was dissolved in 10 ml of dichloromethane, cooled to 0°C, added 300 mg of m-chloroperoxybenzoic acid, kept stirring at 0°C for 1 hour, stirred at room temperature for 2 hours, added 10 ml of water, and separated layers. The aqueous layer was extracted with dichloromethane, the organic phases were combined, dried with anhydrous magnesium sulfate, filtered, concentrated, and the residue was purified by silica gel column chromatography with petroleum ether:ethyl acetate (volume ratio 2:1) as the eluent to obtain white Solid (compound of formula I) 30 mg, yield 24%.
1H NMR(400MHz,CDCl3):δ4.93(m,1H),3.98(dd,1H),3.78(dd,1H),3.67(dd,1H),3.58(dd,1H); 1 H NMR (400MHz, CDCl 3 ): δ4.93(m,1H),3.98(dd,1H),3.78(dd,1H),3.67(dd,1H),3.58(dd,1H);
13C NMR(100MHz,CDCl3):δ68.15,64.87,45.04; 13 C NMR (100MHz, CDCl 3 ): δ68.15, 64.87, 45.04;
HR-EI-MS:153.9761[M]+。HR-EI-MS: 153.9761[M] + .
Claims (22)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310165150.3A CN104140412B (en) | 2013-05-07 | 2013-05-07 | For preparing the intermediate of Bruguiesulfurol, its synthetic method, intermediate and purposes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310165150.3A CN104140412B (en) | 2013-05-07 | 2013-05-07 | For preparing the intermediate of Bruguiesulfurol, its synthetic method, intermediate and purposes |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104140412A CN104140412A (en) | 2014-11-12 |
CN104140412B true CN104140412B (en) | 2016-12-28 |
Family
ID=51849762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310165150.3A Expired - Fee Related CN104140412B (en) | 2013-05-07 | 2013-05-07 | For preparing the intermediate of Bruguiesulfurol, its synthetic method, intermediate and purposes |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104140412B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101210009A (en) * | 2006-12-29 | 2008-07-02 | 中国科学院上海药物研究所 | Neoclamedithiol, its derivatives and their preparation methods and their application in the preparation of drugs for the treatment of diabetes |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2759369B1 (en) * | 1997-02-13 | 1999-04-02 | Essilor Int | NOVEL MONO (THIO) (METH) ACRYLATES, INTERMEDIATE COMPOUNDS FOR THE SYNTHESIS OF THE SAME, POLYMERIZABLE COMPOSITIONS AND POLYMERS OBTAINED THEREFROM AND OPTICAL AND OPHTHALMIC APPLICATIONS THEREOF |
-
2013
- 2013-05-07 CN CN201310165150.3A patent/CN104140412B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101210009A (en) * | 2006-12-29 | 2008-07-02 | 中国科学院上海药物研究所 | Neoclamedithiol, its derivatives and their preparation methods and their application in the preparation of drugs for the treatment of diabetes |
Also Published As
Publication number | Publication date |
---|---|
CN104140412A (en) | 2014-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sá et al. | Synthesis of allylic thiocyanates and novel 1, 3-thiazin-4-ones from 2-(bromomethyl) alkenoates and S-nucleophiles in aqueous medium | |
CN104356109B (en) | A kind of preparation method of 2-((4R, 6S)-6-bromomethyl-2,2-dimethyl-1,3-dioxane-4-base) acetic acid esters | |
CN107513050B (en) | A kind of preparation method of enoic acid bromolactonization | |
US9771317B2 (en) | Process for preparing lacosamide and related compounds | |
JP5646706B2 (en) | Method for producing C-glycoside derivative | |
CN107286092A (en) | The method that methoxy benzamide and diazotate prepare isoquinolin diketone through hydrocarbon functionalization | |
CN103664985B (en) | Stereoselective preparation method of β-hydroxyartemisinic ether | |
CN118598812A (en) | Synthesis method of key intermediate of huperzine A | |
JP7296401B2 (en) | Process for preparing crisabolol and its intermediates | |
CN104140412B (en) | For preparing the intermediate of Bruguiesulfurol, its synthetic method, intermediate and purposes | |
RU2631323C2 (en) | Method for production of 4-benzyl-1-phenethyl-piperazin-2,6-dione, intermediate compound and method for its production | |
CN101967075A (en) | Method for synthesizing terminal alkyne compound by using 3-aryl-2,3-dibromopropionic acid | |
CN101973996B (en) | Imide biotin intermediate monoester and preparation method and use thereof | |
BR112020010618B1 (en) | METHOD FOR PREPARING SALICYLAMINE ACETATE | |
JP2019509293A (en) | 4-Pentafluorothiophenol compounds and preparation method, and preparation method of pentafluorosulfur-substituted benzopyran compounds | |
CN111116493B (en) | A kind of method for preparing Apabetalone, intermediate and preparation method thereof | |
WO2022134262A1 (en) | Dipyrromethene-1-one compound and preparation method therefor | |
CN110343117B (en) | Process for the preparation of artemisinin derivatives | |
CN107353266B (en) | A kind of preparation method that olefin(e) acid bromine lactonizes | |
CN104803895B (en) | A kind of method for preparing sulfinic acid ester as raw material with benzenesulfonylmethyl isonitrile | |
CN111662233B (en) | Method for synthesizing 4-chloro-1H-imidazole-2-carboxylic acid ethyl ester by one-step method | |
CN103539796A (en) | Preparation method of levo praziquantel as well as intermediate thereof | |
CN112430205B (en) | Preparation method of arylpyrrole compound | |
CN108727323A (en) | A kind of method that N-heterocyclic carbine catalyzes and synthesizes trifluoromethyl substitution homoisoflavone class compound | |
CN104910164A (en) | Method for synthesizing 3,6-dichloroimidazo[1,2-b]pyridazine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20161228 Termination date: 20170507 |